跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,569 条关于
“American Headache Society”
全部
11,569
临床试验
4,276
药物
58
机构
267
资讯
6,968
8年前
Alder BioPharmaceuticals to Showcase Eptinezumab's Efficacy in Migraine Prevention at AHS Meeting
去年
Migraine Treatment Advances: CGRP Inhibitors, Digital Therapeutics, and Novel Compounds Highlight 2024
18天前
New AAN and AHS Guidelines Expand Pharmacological Options for Migraine Prevention
去年
Theranica's Nerivio REN Wearable Shows Sustained Migraine Efficacy Over Three Years in Real-World Studies
去年
Rimegepant Shows Consistent Efficacy and Safety in Pooled Migraine Trial Analysis
去年
AbbVie's Atogepant Demonstrates Superior Tolerability and Efficacy Over Topiramate in Phase 3 Migraine Prevention Trial
去年
Lundbeck's Vyepti Demonstrates Sustained Efficacy in Migraine Prevention at AAN 2025
7年前
Alder BioPharmaceuticals Presents New Data on Eptinezumab's Clinical Profile for Migraine Prevention
2个月前
BetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical Officer to Lead BETR-001 Toward Migraine IND
去年
Scilex Seeks FDA Approval for ELYXYB in Acute Pain Management
第 1 页,共 697 页
上一页
下一页